aTyr Pharma

$3.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.11%) Today
+$0.10 (+2.82%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell aTyr Pharma and other stocks, options, and ETFs commission-free!

About LIFE

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. It operates in a single accounting segment. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA. The listed name for LIFE is aTyr Pharma, Inc. Common Stock.

CEO
Sanjay S. Shukla
Employees
44
Headquarters
San Diego, California
Founded
2005
Market Cap
36.16M
Price-Earnings Ratio
Dividend Yield
Average Volume
107.04K
High Today
$3.70
Low Today
$3.52
Open Price
$3.64
Volume
46.29K
52 Week High
$7.62
52 Week Low
$2.13

Collections

LIFE Earnings

-$2.74
-$1.74
-$0.75
$0.25
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 25, After Hours

You May Also Like